Characterization of a New AAV Vector Targeting Expression of Transthyretin to the Correct Tissues after Systemic Delivery in Mice

被引：0
|
作者：
Batista, Ana Rita [1 ]
Sena-Esteves, Miguel [1 ]
机构：
[1] Univ Massachussets, Sch Med, Dept Neurol, Horae Gene Therapy Ctr, Worcester, MA USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
185
引用
收藏
页码：97 / 97
页数：1
相关论文
共 43 条
  • [31] Dorsal root ganglion toxicity after AAV intra-CSF delivery of a RNAi expression construct into non-human primates and mice
    Hawley, Zachary C. E.
    Pardo, Ingrid D.
    Cao, Shaolong
    Zavodszky, Maria I.
    Casey, Fergal
    Ferber, Kyle
    Luo, Yi
    Hana, Sam
    Chen, Shukkwan K.
    Doherty, Jessica
    Costa, Raquel
    Cullen, Patrick
    Liu, Yuqing
    Carlile, Thomas M.
    Chowdhury, Twinkle
    Doyle, Benjamin
    Clarner, Pete
    Mangaudis, Kevin
    Guilmette, Edward
    Bourque, Shawn
    Koske, David
    Nadella, Murali V. P.
    Trapa, Patrick
    Hawes, Michael L.
    Raitcheva, Denitza
    Lo, Shih-Ching
    MOLECULAR THERAPY, 2025, 33 (01) : 215 - 234
  • [32] Long-term systemic expression of a new PD-1 blocking antibody from an AAV vector provides antitumor activity without toxicity
    Silva-Pilipich, N.
    Martisova, E.
    Ballesteros-Briones, M. C.
    Smerdou, C.
    Vanrell, L.
    HUMAN GENE THERAPY, 2019, 30 (11) : A57 - A57
  • [33] Improved brain expression of iduronate sulfatase in the MPS II mouse after intravenous delivery of a self-complimentary adeno-associated viral (AAV) vector
    Muenzer, Joseph
    Wilkie, Mary Beth
    McCarty, Douglas M.
    Fu, Haiyan
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S68 - S68
  • [34] Systemic delivery of immunosuppressant proteins and dystrophin by high-capacity adenoviral vector provides sustained expression of dystrophin in skeletal muscle of mdx mice
    Jiang, ZL
    Clemens, PR
    MOLECULAR THERAPY, 2003, 7 (05) : S321 - S321
  • [35] Muscle Force Improvement by Long-Term Systemic Expression of an AAV9 Minidystrophin after Delivery in Young Adult GRMD Dogs without Immune Suppression
    Li, Juan
    Qiao, Chunping
    Bogan, Dan
    Tang, Ruhan
    Bogan, Janet
    Bian, Tao
    Li, Jianbin
    Dow, Jennifer
    Yuan, Zhenhua
    Grieger, Joshua C.
    Samulski, Richard Jude
    Kornegay, Joe
    Xiao, Xiao
    MOLECULAR THERAPY, 2012, 20 : S69 - S69
  • [36] Ly6a Receptor Affinity Impacts the Blood-Brain Barrier Penetration and Tissue Targeting Properties of AAV9-PHP.B Vectors After Systemic Delivery
    Martino, Richard A.
    Sims, Joshua
    Wang, Qiang
    Wilson, James M.
    MOLECULAR THERAPY, 2022, 30 (04) : 74 - 74
  • [37] Ly6a Receptor Affinity Impacts Blood-Brain Barrier Penetration and the Tissue Targeting Properties of AAV9-PHP.B Vectors after Systemic Delivery
    Martino, R. Alexander
    Sims, Joshua
    Wang, Qiang
    Hu, Gui
    Wilson, James M.
    MOLECULAR THERAPY, 2021, 29 (04) : 147 - 147
  • [38] Cardiac-specific gene expression after systemic administration to adult mice using pseudotyped AAV vectors and the cardiac troponin-T promoter: Comparison with direct injection
    Prasad, Konkal-Matt R.
    Xu, Yaqin
    Yang, Zequan
    Berr, Stuart S.
    French, Brent A.
    CIRCULATION, 2007, 116 (16) : 65 - 65
  • [39] Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector
    Passini, MA
    Wolfe, JH
    JOURNAL OF VIROLOGY, 2001, 75 (24) : 12382 - 12392
  • [40] Cellular Analysis After Systemic Delivery of AAV8-GFP Under Control of Liver-Specific Promoter Elements Shows Transgene Expression in Hepatocytes and Liver Sinusoidal Endothelial Cells (LSECs)
    Lindgren, Jonathan R.
    Sabatino, Denise E.
    Fama, Rosella
    Nguyen, Giang
    Henriksen, Allysen
    Follenzi, Antonia
    Borroni, Ester
    MOLECULAR THERAPY, 2022, 30 (04) : 326 - 327
12345